Abstract:Proteomic analysis aims at characterizing proteins on a large scale, including their relative abundance, post-translational modifications, protein-protein interactions and so on. Proteomic profiling helps to elucidate the mechanisms of disease occurrence and to discover new diagnostic markers and therapeutic targets. Mass spectrometry (MS)-based proteomic technologies have advanced to allow comprehensive qualitative and quantitative proteome profiling across a myriad proteins in cells and tissues. High-throughput proteomics is the core technique for large-scale protein characterization. With the increased demand for large cohort proteomic analysis in the biomedical research field, high-throughput proteomic analysis has become a critical issue that needs to be urgently addressed. The standard shotgun proteomic workflow comprises four steps, including sample preparation, peptide separation, MS acquisition, and data analysis. Advances in these four steps have contributed to the development of high-throughput proteomics. In this review, we aimed at summarizing the current information on the state-of-the-art development of high-throughput proteomic analysis, mainly including the following topics: (1) High-throughput, automatic proteomic sample preparation methods based on liquid-handling workstations. The automation of the proteomic sample preparation steps is essential for high-throughput proteomic analysis, which will significantly reduce variation of manual operation and sample loss by multistep sample processing. The commercial liquid handling workstations, including King FisherTM Flex, Agilent Bravo, AssayMAP Bravo, and Biomek® NXP, perform the handling steps of 96- or 384-channel microplate formats using a mechanical arm that increases the throughput and robustness of sample preparation. (2) High-throughput proteomic detection methods based on microliter-flow-rate liquid chromatography coupled with mass spectrometry (micro-flow LC-MS/MS). Nanoliter-flow-rate liquid chromatography coupled with mass spectrometry (Nano-flow LC-MS/MS) is widely used in classic proteomic research due to its excellent sensitivity, which often comes at the expense of robustness. Owing to the improved robustness and decreased injection-to-injection overheads, micro-flow LC-MS/MS has become increasingly popular in high-throughput proteomic analysis. (3) Using MS instrumentation with high sensitivity and fast scanning speed to realize in-depth proteomic analysis coupled with short chromatographic gradient separation. In recent years, new MS instrumentation continues to exhibit speed of analysis and sensitivity enables the large-scale profiling of hundreds of samples. In particular, ion mobility-based MS, such as timsTOF Pro and Exploris 480 equipped with a front-end high field asymmetric waveform ion mobility spectrometry (FAIMS), which provides fast, sensitive, and robust proteome profiling, thus shifting proteomics to the high-throughput era. (4) Artificial intelligence-, deep neural network-, and machine learning-based proteome data analysis methods. These approaches have improved comprehensive proteomic analysis efficiency. Specifically, the emergence of new algorithms and the up gradation of search engines accelerate the process of high-throughput data analysis. Additionally, the challenges and future development of high-throughput proteomics are prospected. In conclusion, high-throughput proteomic technologies are expected to gradually "transform" and become powerful tools for large cohort proteomic analysis in the near future.

Ultra-high-throughput mass spectrometry in drug discovery: fundamentals and recent advances

Advances in high‐throughput mass spectrometry in drug discovery

Data processing for high-throughput mass spectrometry in drug discovery

Automated MALDI Target Preparation Concept: Providing Ultra-High-Throughput Mass Spectrometry–Based Screening for Drug Discovery

Biochemical applications of mass spectrometry in pharmaceutical drug discovery

Coupling Droplet Microfluidics with Mass Spectrometry for Ultrahigh-Throughput Analysis Up to and above 30Hz.

High-Throughput Native Mass Spectrometry Screening in Drug Discovery

Advances in high‐resolution mass spectrometry applied to pharmaceuticals in 2020: A whole new age of information

Advances in Ultra-High-Resolution Mass Spectrometry for Pharmaceutical Analysis

Current Applications of Liquid Chromatography/Mass Spectrometry in Pharmaceutical Discovery After a Decade of Innovation

Advances in High-Throughput Proteomic Analysis

High-throughput Liquid Chromatography/mass Spectrometry Method for the Quantitation of Small Molecules Using Accurate Mass Technologies in Supporting Discovery Drug Screening.

Pharmaceutical applications of affinity-ultrafiltration mass spectrometry: Recent advances and future prospects

Mass spectrometry‐based high‐throughput proteomics and its role in biomedical studies and systems biology

LC-MS vs. GC-MS, Online Extraction Systems, Advantages of Technology for Drug Screening Assays

Ultra-fast proteomics with Scanning SWATH

It is time for a paradigm shift in drug discovery bioanalysis: from SRM to HRMS

Future technology insight: mass spectrometry imaging as a tool in drug research and development

Recent Development in Liquid Chromatography/Mass Spectrometry and Emerging Technologies for Metabolite Identification

Advances in Application of Mass Spectrometry in High-throughput and Rapid Detection

Open-access liquid chromatography/mass spectrometry in a drug discovery environment.